Tyskland - tysk - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

baxter deutschland gmbh - hydroxyethylstärke (ph.eur.), natriumchlorid - infusionslösung - hydroxyethylstärke (ph.eur.) 100.g; natriumchlorid 9.g

Tyskland - tysk - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

baxter deutschland gmbh - hydroxyethylstärke (ph.eur.), natriumchlorid - infusionslösung - hydroxyethylstärke (ph.eur.) 60.g; natriumchlorid 9.g

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

fresenius kabi new zealand limited - hydroxyethyl starch 130/0.4 60 g/l; magnesium chloride hexahydrate 0.3 g/l;  ; potassium chloride 0.3 g/l; sodium acetate trihydrate 4.63 g/l;  ; sodium chloride 6.02 g/l;  ;  ;   - solution for infusion - 6 % - active: hydroxyethyl starch 130/0.4 60 g/l magnesium chloride hexahydrate 0.3 g/l   potassium chloride 0.3 g/l sodium acetate trihydrate 4.63 g/l   sodium chloride 6.02 g/l       excipient: hydrochloric acid sodium hydroxide water for injection - treatment of hypovolaemia due to acute blood loss when chrystlloids alone are not considered sufficient. the use of volulyte is not a substitute for the appropriate use of packed red blood cells or fresh frozen plasma.

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

fresenius kabi new zealand limited - hydroxyethyl starch 130/0.4 6% (molar substitution 0.38-0.45, av. mwt. 130,000 daltons); sodium chloride 0.9%; hydroxyethyl starch 130/0.4 6% (molar substitution 0.38-0.45, av. mwt. 130,000 daltons) - solution for infusion - active: hydroxyethyl starch 130/0.4 6% (molar substitution 0.38-0.45, av. mwt. 130,000 daltons) sodium chloride 0.9% excipient: hydrochloric acid sodium hydroxide water for injection active: hydroxyethyl starch 130/0.4 6% (molar substitution 0.38-0.45, av. mwt. 130,000 daltons) excipient: hydrochloric acid sodium chloride sodium hydroxide water for injection - treatment of hypovolaemia due to acute blood loss when chrystlloids alone are not considered sufficient. the use of voluven is not a substitute for the appropriate use of packed red blood cells or fresh frozen plasma.

Israel - engelsk - Ministry of Health

cure medical & technical supply - sodium chloride; starch etherified - solution for infusion - starch etherified 60 g/l; sodium chloride 9 g/l - blood substitutes and plasma protein fractions - therapy and prophylaxis of hypovolemia, acute normovolaemic haemodilution technique.

Taiwan - kinesisk - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

信東生技股份有限公司 桃園市桃園區介壽路２２號 (43211700) - hydroxyethyl starch (200/0.5);;sodium chloride - 注射劑 - sodium chloride (4012002100) 9mg; hydroxyethyl starch (200/0.5) (9600009067) 60mg - blood substitutes and plasma protein fractions - 單獨使用晶質輸注液無法治療之急性出血導致之低血容積病人，本品無法取代紅血球及血漿中的凝血因子

Irland - engelsk - HPRA (Health Products Regulatory Authority)

b. braun melsungen ag - poly(o-2-hydroxyethyl)starch, sodium chloride, potassium chloride, calcium chloride dihydrate, magnesium chloride hexahydrate, sodium acetate trihydrate, l-malic acid dab - solution for infusion - 60 mg/ml - blood substitutes and plasma protein fractions

Irland - engelsk - HPRA (Health Products Regulatory Authority)

b. braun melsungen ag - poly(o-2-hydroxyethyl)starch, sodium chloride, potassium chloride, calcium chloride dihydrate, magnesium chloride hexahydrate, sodium acetate trihydrate, l-malic acid dab - solution for infusion - 60 mg/ml - blood substitutes and plasma protein fractions

Irland - engelsk - HPRA (Health Products Regulatory Authority)

b. braun melsungen ag - poly(o-2-hydroxyethyl)starch, sodium chloride, potassium chloride, calcium chloride dihydrate, magnesium chloride hexahydrate, sodium acetate trihydrate, l-malic acid dab - solution for infusion - 100 mg/ml - blood substitutes and plasma protein fractions

Irland - engelsk - HPRA (Health Products Regulatory Authority)

b. braun melsungen ag - poly(o-2-hydroxyethyl)starch, sodium chloride, potassium chloride, calcium chloride dihydrate, magnesium chloride hexahydrate, sodium acetate trihydrate, l-malic acid dab - solution for infusion - 100 mg/ml - blood substitutes and plasma protein fractions